今日上海
全球首个治疗系统性红斑狼疮生物制剂亮相进博会 - 2021年11月08日
GSK biological agent offer hope for lupus nephritis sufferers
The world's first biological agent treating lupus nephritis has been introduced at the 4th China International Import Expo.
Lupus nephritis is a kidney complication of systemic lupus erythematosus, an autoimmune disease in which the immune system of the body mistakenly attacks healthy tissue and can affect the skin, joints, kidneys, brain and other organs.
There are about 1 million people with SLE in China, which has the highest incidence in the world.
